Horizon BCBS of New Jersey Provides Coverage for Biodesix VeriStrat Test
The blood-based proteomic test for patients with advanced non-small cell lung cancer is now covered for another 3.8 million patients living in eastern United States.
Read More
Search Results for: lung cancer
Streck, Biodesix Team Up for Blood Sample Collection
The companies have signed an agreement to make Streck the exclusive supplier of DNA and RNA tubes for Biodesix.
Read More
Multitemplate Liquid Biopsies
Improvements in liquid biopsy techniques are offering a more holistic view of cancer.
Read MoreInside Track: A Fresh Look at Colorectal Cancer
David A. Ahlquist, MD, coinventor of the Cologuard stool-based DNA screening test for colorectal cancer, discusses updated USPSTF guidelines that seek to increase screening rates.
Read More
Investors Back Disease Breathalyzer
Owlstone Medical Ltd, Cambridge, UK, has been spun out of parent company Owlstone Inc to develop and commercialize a breathalyzer for use in clinical diagnostics and precision medicine, with applications in cancer, and inflammatory and infectious disease.
Read More